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Summary
 
After productive rearrangement of a TCR
 
b
 
 chain gene, CD4
 
2
 
8
 
2
 
 double negative (DN) thy-
mocytes express TCR
 
b
 
 polypeptide chains on the cell surface together with pre-T
 
a
 
 and the
CD3 complex forming the pre-TCR. Signals transmitted through the pre-TCR select
TCR
 
b
 
1
 
 DN thymocytes for further maturation to the CD4
 
1
 
8
 
1
 
 double positive stage, whereas
DN cells that fail to generate a productive TCR
 
b
 
 gene rearrangement do not continue in de-
velopment. This process is termed TCR
 
b
 
 chain selection. Although it is likely that differences
between proliferation dynamics of TCR
 
b
 
1
 
 and TCR
 
b
 
2
 
 cells may play a role, the exact mech-
anisms of TCR
 
b
 
 chain selection have not been elucidated. We therefore studied the prolifera-
tion dynamics of TCR
 
b
 
1
 
 and TCR
 
b
 
2
 
 thymocytes during fetal development, i.e., when
TCR
 
b
 
 chain selection takes place for the first time. We analyzed in situ accumulation of
TCR
 
b
 
1
 
 thymocytes by confocal microscopy, and determined cell cycle and division parame-
ters of TCR
 
b
 
1
 
 and TCR
 
b
 
2
 
 populations by flow cytometry. About 600 TCR
 
b
 
1
 
 cells/thymic
lobe are generated by independent induction events between days of gestation (dg) 13.5. and
15.5. As of dg 14.5, most TCR
 
b
 
1
 
 cells have entered S/G2 phase of cell cycle, followed by
seven to eight rapid cell divisions in fetal thymic organ culture, suggesting a corresponding
burst of nine cell divisions within 4 d in vivo. By dg 18.5, the division rate of TCR
 
b
 
1
 
 cells has
slowed down to less than 1/d. About three quarters of TCR
 
b
 
2
 
 cells divide at a slow rate of 1/d
on dg 14.5, the proportion of nondividing cells increasing to 50% within the following four d.
From dg 16.5 onwards, TCR
 
b
 
2
 
 cells, but not TCR
 
b
 
1
 
 cells, contain a significant proportion
of apoptotic cells. The results suggest that failure to become selected results in shutdown of
proliferation and eventual programmed cell death of fetal TCR
 
b
 
2
 
 cells. Positive selection of
fetal TCR
 
b
 
1
 
 cells is achieved by an increased rate of cell divisions lasting for approximately 4 d.
 
D
 
uring development in the thymus, 
 
ab
 
 lineage thy-
mocytes proceed through two main developmental
 
checkpoints. First, cells with a CD4/CD8 double negative
(DN)
 
1
 
 phenotype differentiate to CD4/CD8 double posi-
tive (DP) cells. Second, DP thymocytes develop into CD4
or CD8 single positive (SP) cells (reviewed in reference 1).
Progression through either of these checkpoints is the result
of a process of selection (reviewed in reference 2). Differ-
entiation of DN to DP cells depends on the expression of
the pre-TCR, consisting of the TCR
 
b
 
 chain, pre-T
 
a
 
 (3, 4),
and components of the CD3 complex (reviewed in 5–9).
Differentiation of DP to SP cells depends on the expression
of a mature TCR, consisting of the TCR
 
ab
 
 heterodimer
and the CD3 complex (2, 10). The TCR
 
b
 
 genes rearrange
during the DN stage (11–13), and expression of the pre-
TCR selects for the approximately 56% of rearranging cells
that statistically generate a productive TCR
 
b
 
 gene (14).
The TCR
 
a
 
 genes rearrange during the DP stage (15).
Thus, selection by the pre-TCR, also termed TCR
 
b
 
 chain
selection, generates the repertoire of TCR
 
b
 
 chains to be
combined with TCR
 
a
 
 chains in the DP stage. A putative
ligand for the selection by the pre-TCR is not known (16).
DP cells expressing the mature 
 
ab
 
TCR are selected, posi-
tively or negatively, by the ability of the 
 
ab
 
TCR to inter-
act with MHC/peptide ligands, thus generating the self tol-
erant, self-MHC restricted repertoire of CD4 or CD8 SP
thymocytes and peripheral T cells (17, 18)
Pre-TCR–induced maturation of DN to DP thymocytes
is associated with a complex cluster of differentiation events
(reviewed in reference 8), including allelic exclusion of the
TCR
 
b
 
 locus (10, 19, 20), initiation of germline transcrip-
tion of the TCR
 
a
 
 locus (20, 21), transient downregulation
of the expression of the RAG genes (20, 22), shutdown of
CD25 (23–25), and transient expression of the activation
marker CD69 (26). Moreover, a large number of DP thy-
mocytes is generated from a small number of DN cells,
presumably by induction of cell proliferation. This expan-
 
1
 
Abbreviations used in this paper:
 
 BrdU, 5-bromo-2
 
9
 
-deoxyuridine; CLSM,
confocal laser scanning microscopy; dg, day of gestation; DN, double
negative; DP, double positive; FCM, flow cytometry; FTOC, fetal thy-
mic organ culture; IC, intracellular; PI, propidium iodide; SP, single pos-
itive.
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Pre-TCR Dependent Fetal Thymocyte Proliferation
 
sion phase is impaired in the absence of TCR
 
b
 
 (27–32) or
of pre-T
 
a
 
 (33). However, TCR
 
b
 
-deficient DN thymo-
cytes can be induced to proliferate and to differentiate to
DP cells by cross-linking CD3
 
e
 
, expressed on DN thy-
mocytes before and independent of TCR
 
b
 
 (23–25, 34).
These results suggested that cell proliferation associated
with the differentiation of DN to DP thymocytes may be
induced by pre-TCR–mediated signal transduction (26).
Cell division parameters of immature thymocytes have
previously been studied in adult mice. Shortman et al. (35)
studied proliferation and turnover of DN thymocytes by
thymidine labeling in vivo and propidium iodide (PI) stain-
ing, and suggested the following sequence: the dividing,
most immature DN CD44
 
1
 
 (PgP-1
 
1
 
) CD25
 
2
 
 (IL-2R
 
a
 
2
 
)
thymocytes mature sequentially through a nondividing
CD25
 
1
 
CD44
 
2
 
 stage into dividing CD25
 
2
 
CD44
 
2
 
 DN
cells before they enter the DP stage and exit cell cycle.
Most of TCR
 
b
 
 rearrangement has been subsequently shown
to take place at the nondividing CD25
 
1
 
CD44
 
2
 
 transitory
stage (12, 13). More recently, Penit et al. (36) reported re-
sults from 5-bromo-2
 
9
 
-deoxyuridine (BrdU) labeling of thy-
mocytes in vivo suggesting that 70% of the CD25
 
1
 
CD44
 
2
 
DN cells were resting while 30% were proliferating. Hoffman
et al. (37) showed that a subset of CD25
 
1
 
CD44
 
2
 
 DN thy-
mocytes expressed markers of cell division, such as CDK2
and cdc2. Since proliferating CD25
 
1
 
CD44
 
2
 
 cells were not
seen in RAG–deficient mice (36, 37), these authors specu-
lated that the proliferating cells might be those that had
produced functional TCR
 
b
 
 genes. However, none of these
studies directly addressed the relationship between TCR
 
b
 
expression and thymocyte proliferation. Parkin et al. (38)
observed mitotic activity in newborn DN TCR
 
b
 
1
 
 thy-
mocytes, but proliferation kinetics of TCR
 
b
 
2
 
 cells have not
been determined. Moreover, cell cycle and division param-
eters in fetal thymic development have not been studied.
The thymic anlage of mice starts to become repopulated
with thymocyte precursors on day of gestation (dg) 11–12.
TCR
 
b
 
 gene VDJ rearrangements were first detected in fe-
tal thymocytes on dg 15.5 (39, 40). Cells expressing TCR
 
b
 
chains were also observed on dg 15.5 by immunohistochem-
istry (41) and flow cytometry (FCM) among CD25
 
1
 
CD44
 
2
 
thymocytes (42). In the present report, we studied the ac-
cumulation and cell cycle dynamics of TCR
 
b
 
1
 
 thymocytes
in ex vivo fetal thymuses and in dg 14.5 fetal thymic organ
cultures (FTOC) during the following four d in vitro, us-
ing confocal laser scanning microscopy (CLSM) and flow
cytometric analyses of PI- and BrdU-labeled cells. We de-
tect TCR
 
b
 
1
 
 cells from dg 13.5 onwards. Before dg 15.5,
TCR
 
b
 
1
 
 cells appear to accumulate mostly by independent
induction events to reach approximately 600 independent
TCR
 
b
 
1
 
 cells/thymic lobe at dg 15.5. Concomitantly,
TCR
 
b
 
1
 
 cells rapidly enter the S/G2 phase of cell cycle. In
FTOC, this is followed by 3 d of rapid proliferation, com-
prising at least seven to eight cell divisions, and an increase in
total TCR
 
b
 
1
 
 cells of almost 200-fold. In vivo data suggest
a corresponding burst of up to nine cell divisions and an ap-
proximately 500-fold expansion between dg 14.5 and 18.5.
Thereafter, TCR
 
b
 
1
 
 cells return to slow cycle conditions.
 
A majority of TCR
 
b
 
2
 
 cells appears to be slowly cycling on
dg 14.5 with a progressive increase in the proportion of
noncycling TCR
 
b
 
2
 
 cells to 50%, resulting in a 8-(in vitro)
to 14-(in vivo) fold overall increase in TCR
 
b
 
2
 
 cells during
the 4 d of observation. A significant proportion of apop-
totic cells is seen from dg 16.5 onwards among TCR
 
b
 
2
 
,
but not among TCR
 
b
 
1
 
 thymocytes.
 
Materials and Methods
 
Mice.
 
BALB/c mice were obtained from our own specific
pathogen-free animal facility. For timed pregnancies, mice were
allowed to mate overnight (5 PM to 7 AM) and screened for vag-
inal plug. Noon of the following day was defined as dg 0.5. For in
vivo labeling, pregnant mice were injected 18 h before analyses of
fetal thymocytes with 250 
 
m
 
g of BrdU (Boehringer Mannheim
GmbH, Mannheim, Germany), and drinking water was supple-
mented with 1 mg/ml of BrdU.
 
Fetal Thymic Organ Culture.
 
Fetal thymic organ cultures were
performed with dg 13.5 or 14.5 thymic lobes as previously de-
scribed (23, 24). Cultures were carried out for 1–4 d, referred to
as day 
 
1
 
1, 
 
1
 
2, 
 
1
 
3, and 14, respectively. BrdU labeling was
done by incubation for 18 h with 10 mM concentration before
analysis.
mAb. The following mAb, labeled with FITC or PE, were
purchased from PharMingen (San Diego, CA): anti-CD44, clone
IMF; anti-TCRb, clone H57-597; anti-TCRVb6, clone RR4-7;
and anti-TCRVb3, clone KJ25. Anti-CD25, clone 5A2, was la-
beled with FITC in our own laboratory. FITC labeled anti-BrdU
clone BMC9318 was from Boehringer Mannheim, GmbH.
FCM. For propidium iodide/intracellular (IC) TCRb dou-
ble staining cells were first incubated with culture supernatant of
mAb 2.4G2 to block FCgRII/III. Cells were then fixed with 1%
paraformaldehyde for 30 min on ice, followed by three washing
steps in PBS/2% FCS, the last containing, in addition, 0.1% sapo-
nin (Lot No. P4170; Sigma Chemical Co., Heidelberg, Ger-
many). FITC labeled anti-TCRb mAb in PBS/0.125% saponin
was added for 20 min on ice, followed by two quick washes with
PBS and 2 3 20 min on a rocking platform in PBS/2% FCS/
0.1% saponin at 48C. Cells were then fixed again in 1% paraform-
aldehyde, washed, incubated for 30 min at 378C with 100 mg/ml
RNAse (Boehringer Mannheim, GmbH) and stained with 20
mg/ml propidium iodide (Sigma Chemical Co.). After washing,
cells were analyzed by FCM on a FACScanÒ (Becton Dickinson,
Mountain View, CA) using gates (signal area versus signal width)
that exclude doublet signals.
BrdU-labeled cells were first stained for intracellular TCRb as
described above, and were sorted into TCRb1 and TCRb2 pop-
ulations using a FACStarÒ plus (Becton Dickinson). Cells were
then fixed with 70% ethanol for 30 min on ice, resuspended in
0.1 M HCl, 0.5% Triton X-100 for 10 min on ice, centrifuged,
and resuspended in H2O. DNA was denatured by heating for 10
min at 958C (43) followed by rapid cooling with ice-cold H2O.
This heating step obliterated all TCRb fluorescence. After one
wash in 0.5% Triton X-100 in PBS, cells were incubated with
FITC-labeled anti-BrdU mAb for 30 min at RT. FCM was done
using a FACScanÒ.
Triple analyses for TCRb, BrdU incorporation, and PI stain-
ing first used a sort for intracellular TCRb, followed by staining
for BrdU incorporation, as described above. PI staining was done
last, also as described above.
Confocal Laser Scanning Microscopy. Whole thymic lobes were2329 Falk et al.
quickly rinsed three times in PBS and then fixed with 2% para-
formaldehyde for 3 h at 48C on a rocking platform. They were
washed twice in PBS, twice in PBS/1% FCS/1% Tween-100,
and then incubated for 7 min in acetone at 2208C. This was fol-
lowed by resuspension in H2O and 2 3 5 min rocking in PBS/
FCS/Tween. For mAb staining fixed lobes were first incubated
for 30 min with unlabeled mAb 2.4 G2 and then for 30 min with
each fluorochrome-labeled mAb alternating with 2 3 30 min
rocking in PBS/FCS/Tween, all at 378C. Lobes were then em-
bedded on microscope slides in Fluoromount-C (Southern Bio-
technology Assoc., Birmingham, AL), covered by a cover slip,
turned upside down, and analyzed by an inverted CLSM instru-
ment (Leica Instrs. GmbH, Heidelberg, Germany). Lobes were
minimally compressed by this technique. Magnification was 400-
fold if not otherwise stated.
PCR for TCRb rearrangement. DNA was prepared from thy-
mocytes as described (39). DNA was amplified in 25-ml reaction
buffer, containing 0.1 mg DNA, 0.5 mM 59 and 39 primers, 200 mM
of each dNTP (Pharmacia, Freiburg, Germany) and 0.2 U Super-
Taq (Staehelin, Basel, Switzerland) for 34 cycles (40 s at 948C, 60
s at 638C, 120 s at 728C). Primers were 59Vb3 (44), 59Vb8,
59Db2, and 39Jb2 (45).
Results
Kinetics of Accumulation of the TCRb1 and TCRb2 Subsets
In Vivo and in FTOC. Fetal thymuses were obtained from
pregnant BALB/c mice from dg 14.5 to 18.5 and FTOC,
were set up using dg 14.5 thymic lobes cultured for one to
four d. Thymocytes were stained on each day for IC TCRb
chain, and Table 1 gives the absolute numbers of TCRb1
and TCRb2 cells determined in both sets of experiments.
About 100 TCRb1 cells/lobe were detected on dg 14.5.
This is not a staining artefact, as TCRb1 cells identified by
FCM on dg 14.5 differ drastically in PI staining pattern
from TCRb2 cells (see Fig. 5). Moreover, we have no dif-
ficulties in demonstrating VDJ rearrangements by PCR in
dg 14.5 thymic lobes (see below, Fig. 7 C). In vivo, num-
bers of TCRb1 cells increased about 10-fold each day until dg
17.5, at which time the majority turned into DP thymocytes
(data not shown; 42). This was followed by a 3–4-fold in-
crease of TCRb1 cells until dg 18.5. TCRb2 cells increased
merely 14-fold over the entire time interval. In vitro, num-
bers of TCRb1 cells increased fourfold during the first day
of culture, and then eight–ninefold on each of the next 2 d
and two–threefold on day four. TCRb2 thymocytes in-
creased about eightfold until day 14 in FTOC. The end
result is a proportion of TCRb1 cells of z80% by day 18.5
in vivo or of z50% after 4 d of FTOC. The comparison
between the cell increments in vitro and in vivo reveals the
main difference between dg 15.5 and day 11 of culture,
presumably reflecting a lag due to the recovery of the thy-
mic lobes from the handling procedures. The differences
later in the time course are smaller and may to some extent
be due to lack of influx of new cells in vitro.
Subset Relationships of Early Fetal TCRb1 Thymocytes.
Expression of intracellular TCRb chains before dg 15.5 has
not been previously described and it was therefore nesses-
sary to determine the subset relationships of these early
TCRb1 thymocytes. To this end, we prepared fetal thymic
lobes from BALB/c mice at dg 13.5 and 14.5 and analyzed
them by CLSM for TCRb and CD44. Fig. 1 shows that
TCRb1 cells are detected as early as dg 13.5. However,
even at this early timepoint, all unequivocally identified
TCRb1 cells were negative for CD44. In a second experi-
ment (Fig. 2), fetal thymic lobes were prepared on dg 14.5,
15.5, and 16.5, and analyzed by CLSM for TCRb and
CD25. Out of 25 individually studied TCRb1 cells on dg
14.5, 14 were were weakly positive (upper panel), and 11
were negative for CD25 (second panel). On dg 15.5 and
16.5, CD25 staining changed from a homogeneous to a
spotty pattern, and the proportion of CD251TCRb1 cells
decreased, in agreement with previous results from FCM
(42). Together, these results suggest that even at this early
stage in development, TCRb expression does not preceed
the CD251CD442 stage of DN thymocytes.
Morphodynamics of the Accumulation of TCRb1 Thymocytes
In Vivo and in FTOC. As shown in Fig. 2, TCRb1 cells
were readily detected on dg 14.5, and increased in density un-
til dg 16.5, in parallel with a decrease in CD251 cells. TCRb1
cells on dg 14.5 are dispersed as rare individual cells whereas
on dg 15.5 some of them appear as doublets or as large di-
viding cells, indicating that cell division may have started.
Ex vivo thymic lobes later than dg 16.5 were not readily
Table 1. Accumulation of TCRb1 and TCRb2 Cells in Early Fetal Thymic Development*
In Vivo In FTOC
TCRb1 TCRb2 TCRb1 TCRb2
dg 14.5 z102 1.1 3 104
dg 15.5 1.22 3 103 (1.22) 2.9 3 104 day11 0.45 3 103 (1.8) 1.5 3 104
dg 16.5 1.12 3 104 (1.18) 4.9 3 104 12 4.1 3 103 (1.67) 2.8 3 104
dg 17.5 1.4 3 105 (1.32) 7.5 3 104 13 3.2 3 104 (1.48) 5.7 3 104
dg 18.5 5.5 3 105 (1.41) 1.5 3 105 14 7.9 3 104 (1.62) 8.5 3 104
*Absolute numbers of thymocytes/thymic lobe estimated from the percentages of TCRbIC1 cells in FCM. Standard errors of the geometric means
of several experiments in parentheses.2330 Pre-TCR Dependent Fetal Thymocyte Proliferation
analyzed by CLSM. Therefore, FTOC were set up with
dg 14.5 thymic lobes and cultured for an additional 4 d. In-
dividual lobes were fixed on each day of culture and dou-
ble stained with mAbs against CD25 and against TCRb
(Fig. 3). The density of TCRb1 cells after 1 d of culture
was higher than on dg 14.5, but appeared lower than on dg
15.5 in ex vivo thymic lobes (see Fig. 2), and most TCRb1
cells were still dispersed individually with doublets rarely
seen. On each of the following 2 d of culture, an increase
in the number of TCRb1 cells was seen, with local accu-
mulations within the field of observation on day 13. A fur-
ther increase in TCRb1 cells was seen on day 14, with the
cells distributed densely over the entire field of observation.
The intensity of CD25 staining and the number of CD251
cells decreased in parallel with the increase in TCRb1
cells, slightly delayed compared to the ex vivo analyses.
The accumulation of TCRb1 cells in FTOC was also
studied using mAb to individual TCR Vb gene products.
Fig. 4 shows analyses using mAb to Vb3 and Vb6, which
gave the best signal to noise ratios. For both TCR Vb gene
products, rare individual cells and a few doublets could be
detected on day 11 and cellular clusters were detected
from day 12 onwards. These clusters are interpreted as di-
viding TCRb clones. For unkown reasons, cluster mor-
phology differed between clones expressing TCRVb3 and
TCRVb6, the former showing tightly packed and the lat-
ter showing more loosely associated accumulations of cells.
Attempts were made to estimate cluster sizes by a combina-
tion of counting cells in individual scans taken at 3 m inter-
vals, and by superimposing 3 m scans from top to bottom
through a cluster. The results are compiled in Table 2 and
suggest that clusters on day 12 range from 4 to 14 cells
with clusters of 6 to 8 cells predominating. On day 13 es-
timates were more difficult, suggesting an average of 30 to
40 cells/cluster. Estimates of cluster sizes on day 14 were
not possible, but a further increase in cluster size was apparent
(not shown). These data suggest that individual TCRb1
cells begin to proliferate in FTOC during day 11 and run
through at least five cell divisions within the following 2 d,
with additional cell divisions thereafter.
Cell Cycle Analysis by Propidine Iodide Staining. FTOC were
used to focus the cell cycle analyses on a population that
entered the thymus within a limited time window and was
therefore expected to develop in a quasi-synchronous fash-
ion. To this end, FTOC were set up on dg 14.5, and cells
were double stained with anti-TCRb mAb and PI imme-
diately and on each of 4 d of culture. As shown in Fig. 5,
TCRb1 cells contain high proportions of cells with hyper-
diploid concentrations of DNA, characteristic of the S/G2
phases of the cell cycle. The proportion of TCRb1 cells in
S/G2 is highest on dg 14.5, and decreases only slightly until
day 14. This suggests that virtually all TCRb1 cells are in
cell cycle for the entire period of observation. The percent-
ages of cells in S/G2 among TCRb2 cells are considerably
lower, and decrease from z30% on dg 14.5 to ,10% on
day 14 of culture. Nevertheless, these data show that on
dg 14.5 and during the initial days of culture, the TCRb2
subset contains a significant proportion of cycling cells as
Figure 1. Confocal laser scanning microscopy of fetal thymic lobes recovered from BALB/c fetuses on dg 13.5 and 14.5. Two examples of dg 14.5
are shown. Left, Staining with FITC labeled anti-CD44; right, PE-labeled anti-panTCRb; center, two color representation. Horizontal side length of one
field is 100 mm.2331 Falk et al.
Figure 2. Confocal laser scanning microscopy of fetal thymic lobes recovered from BALB/c fetuses on dg 14.5, 15.5, and 16.5. Two examples of dg
14.5 are shown. Left, staining with FITC-labeled mAb to CD25; right, PE-labeled anti-panTCRb mAb; center, two color representation. Note that the
TCRb1 cell in the upper example of dg 14.5 is CD25low, and in the lower example is CD252. The side length of one square field is 100 mm.2332 Pre-TCR Dependent Fetal Thymocyte Proliferation
Figure 3. Confocal laser scanning microscopy of fetal thymic lobes recovered from BALB/c fetuses at dg 14.5 and kept in organ culture for 1–4 d.
Left, FITC-labeled anti-CD25; right, PE-labeled anti-panTCRb; center, two color representation. The side length of one square field is 100 mm.2333 Falk et al.
well. Proportions of blastoid cells were in good agreement
with cells in S/G2 in all cases. Note, from day 12 onwards,
small proportions of cells with hypodiploid DNA content
are seen among the TCRb2, but not among the TCRb1
population. The detection of hypodiploid cells in only one
of the two subsets argues against a tissue culture artefact
(also see below) and suggests that TCRb2 cells may even-
tually die by apoptosis.
Proliferation Kinetics by Labeling with BrdU. For labeling
with BrdU, we sorted TCRb1 and TCRb2 cells from
FTOC preincubated with BrdU, and stained them with
anti-BrdU mAb after denaturation of the DNA by heating
to 908 (43). This method reliably permitted the differentia-
tion of two distinct levels of BrdU incorporation, appar-
ently corresponding to partial and saturating DNA labeling.
Since the results from CLSM suggested that TCRb1 fetal
thymocytes divide at least 2–3 times/day between days 11
and 13 of FTOC, we chose a labeling period of 18 h be-
fore analysis. During this time interval, nearly all asynchro-
nously dividing cells with a cycle time of less than nine h
should have acquired a saturating BrdU label, whereas
longer cycle times should have been revealed by increasing
proportions of partially labeled and unlabeled cells. The re-
sults of representative experiments for each day are com-
Figure 4. Confocal laser scanning micros-
copy of fetal thymic lobes obtained from
BALB/c fetuses on dg 14.5 and kept in organ
culture for 1–3 d. PE-labeled anti-Vb3 and
anti-Vb6 mAb used for staining, as indicated.
For each cluster, a single optical section is
shown. The total number of cells/cluster is
usually considerably larger than the number of
cells seen in the sections shown ( see Table 2).
Table 2. Sizes of TCRb Clusters in FTOC*
Day of culture
11 12 13
Vb3 11 3 1,2,2,3 4,5,6,6,9,11,14 23,24,32,33,42
(1.3) (7.8) (31)
Vb6 14 3 1,2,3 5,6,6,8‡ 29,34,37,45,46
(1.2) (6.25) (38.2)
*Cluster sizes determined by confocal laser scanning microscopy by
scanning optical sections at 3 mm intervals. For examples see Fig. 4.
‡Due to the loose association of Vb61 cells, only a few safe examples of
clusters could be analyzed.2334 Pre-TCR Dependent Fetal Thymocyte Proliferation
piled in Fig. 6. TCRb1 cells on day 11 fell into three
categories: one third remained unlabeled, one third incor-
porated a partial, and one third incorporated a saturating
dose of BrdU. On day 12, the vast majority of TCRb1
cells had incorporated a saturating dose, whereas this pro-
portion dropped to z50% on day 13. On day 14, nearly
all of the TCRb1 cells showed partial BrdU labeling.
About 20–25% of the TCRb2 cells remained unlabeled
from day 11 to d 13, whereas the rest of the cells incor-
porated a partial BrdU label. By day 14, the proportion of
unlabeled TCRb2 cells increased to 50%. Together, these
results suggest that TCRb1 cells enter a phase of rapid pro-
liferation on day 11 of FTOC with some of the cells going
through at least one division. Essentially all of the cells
progress through at least three divisions on day 12, and
most of the cells through another three divisions on day
13. On day 14, most TCRb1 cells divide at least once
more while turning back to slow cycle conditions. Most of
the TCRb2 cells maintain a slow cycle throughout the first
3 d of culture with no more than one division per day and
a reduction in the proportion of cycling cells to 50% until
day 14.
The results of BrdU incorporation suggested that the
phase of rapid divisions of TCRb1 cells only begins on day
11 in FTOC (Fig. 6). In contrast, PI staining showed
.60% of TCRb1 cells to be in S/G2 already in dg 14.5 ex
vivo thymic lobes (Fig. 5). The incomplete BrdU incorpo-
ration into TCRb1 cells on day 11 of dg 14.5 FTOC
could indicate an intermittant slowdown of proliferation
due to the transfer of the thymic lobes to in vitro condi-
tions. Alternatively, it was possible that TCRb1 cells re-
main in a prolonged S/G2 phase through dg 14.5 and most
of dg 15.5 before actually undergoing their first division. In
the latter case, only unlabeled and partially BrdU labeled
TCRb1 cells should be seen in dg 13.5 FTOC incubated
with BrdU for 18 h before analysis on day 13.511. As
shown in Fig. 7 A, the BrdU incorporation patterns after 1 d
of culture of dg 13.5 FTOC were similar to those of dg
14.5 FTOC, with an even higher proportion of TCRb1
cells labeled to saturation. These data suggest that dg 13.5
TCRb1 thymocytes have at least a similar capacity for pro-
liferation in vitro as have dg 14.5 TCRb1 cells. Moreover,
we reasoned that if the onset proliferation of TCRb1 cells
in vivo was delayed until late dg 15.5, only the cells in
S/G2, and not the cells in G1 phase of cell cycle on that
day, should have incorporated BrdU injected into the
pregnant mothers 18 h earlier. As shown in Fig. 7 B, label-
ing in vivo was not as efficient as in vitro, and did not per-
mit a quantitative determination of unlabeled, as compared
to partially and completely labeled, cells. Nevertheless, the
data show that both G1 and S/G2 phase TCRb1 cells on
dg 15.5 incorporated BrdU under these conditions in vivo.
Figure 5. Cell cycle analysis by PI staining of TCRb1 and TCRb2 thymocytes from fetal thymic lobes recovered from BALB/c fetuses at dg 14.5,
and from dg 14.5 FTOC cultured for 1–4 d. Thymocytes were double stained for intracellular TCRb (TCRbIC, top) and PI. The lower panels show the
PI staining (shaded patterns) of cells gated positively or negatively for TCRb. Percentages of TCRb1 cells and of cells with hypodiploid, diploid, and hy-
perdiploid amounts of DNA are given in each frame. LC, percentage of large blastoid cells as determined by scatter parameters.2335 Falk et al.
These results support our conclusions from CLSM analyses
and suggest that TCRb1 thymocytes start cell divisions as
early as dg 14.5 in vivo, and that transfer to in vitro condi-
tions causes a lag in the onset of proliferation. The data in
Fig. 7 B further reveal that dg 15.5 and 17.5 TCRb2 cells
in both G1 and S/G2 phases of cell cycle incorporated
BrdU injected 18 h earlier into the pregnant mothers.
These data support the in vitro results in that they are con-
sistent with a division rate of once per day for the major
proportion of TCRb2 cells. Finally, and also in support of
the in vitro results, dg 17.5 TCRb2, but not TCRb1, cells
contain a proportion of hypodiploid cells suggesting ongo-
ing cell death by apoptosis in this population.
The experiment in Fig. 7 C demonstrates that PCR
analysis yielded fragments corresponding to TCRb VDJ
rearrangements in dg 14.5 thymocytes, together with stron-
ger signals for DJ rearrangements and a strong germ line
fragment. In contrast to adult thymus, VDJ rearrangements
at dg 14.5 display only some of the six Jb2 segments, pre-
sumably reflecting the paucity of rearranged TCR Vb
genes at that time. These data support our serological de-
tection of TCRb1 cells in dg 14.5 thymocytes.
Discussion
During thymic development, a large number of DP thy-
mocytes arise from a small number of DN cells. While this
process most likely involves cell proliferation, the extent of
cell division cannot be judged from the pool sizes of DN
and DP cells, as these are strongly influenced by parameters
unrelated to cell division, such as entry rates, exit rates, and
mean survival times (46). The present paper describes an
attempt to obtain numerical information on cell divisions
that occur during the generation of DP cells, using a com-
bination of morphodynamic studies in situ with cell cycle
analyses. To focus on cells that have entered the thymus
during a defined temporal window in fetal life, most analy-
ses have been done in thymic organ cultures. While it is
clear that the increment in thymic cellularity during fetal
life in vivo exceeds that in vitro, a proportion of the addi-
tional increment in vivo is obviously due to continuous in-
flux of new cells into the thymus. Another proportion of
the difference may be due to suboptimal conditions in
vitro, so that numbers and rates of cell divisions determined
in these studies obviously represent lower estimates. How-
ever, our comparisons of cell accumulation in vitro and in
vivo localize the major deficit of FTOC to the first day of
culture so that our data provide a reasonable basis for esti-
mates of fetal thymocyte proliferation in vivo.
Differentiation of DN to DP cells is dependent on the
expression of the TCRb chain, most likely as part of the
pre-TCR. Fetal thymocytes expressing TCRb polypep-
tides have first been reported on dg 15.5 (41, 42). We were
surprised to see TCRb1 cells as early as dg 13.5 by CLSM
and attribute the increased sensitivity to the capacity to
search for individual fluorescent cells by scanning through
the entire thymic organ. Since thymic repopulation begins
around dg 11 to 12, it appears that TCRb rearrangement
Figure 6. BrdU incorporation in fetal thy-
mic lobes recovered from BALB/c fetuses on
dg 14.5 and kept in organ culture for 1–4 d.
BrdU was added to the culture medium 18 h
before termination of culture. Thymocytes
were stained for TCRb (upper panels, percent-
ages of TCRb1 cells indicated), sorted into
TCRb2 and TCRb1 cells (second panels,
cross-hatched and dotted patterns, respec-
tively), and analyzed for BrdU incorporation
(third and fourth panels). Note the three levels
of BrdU staining (vertical stripes). Percentages
of BrdU negative cells and of partially and
completely BrdU-labeled cells indicated in
each frame. Negative controls (shaded) used
thymocytes recovered from thymic lobes cul-
tured without BrdU, and then incubated with
BrdU for 30 min on ice, washed, and sub-
jected to the antiBrdU staining procedure.2336 Pre-TCR Dependent Fetal Thymocyte Proliferation
may either be complete within 2 d of thymic arrival, or
that some cells may enter the thymus with previous TCRb
VDJ rearrangements. The latter possibility is not excluded
by our data; although we never saw CD441TCRb1 thy-
mocytes on dg 13.5 or 14.5, biosynthesis of the TCRb
chain may be delayed after rearrangement. However, the
developmental stage of TCRb gene rearrangement previ-
ously determined in adult mice (11–13) seems to hold for
fetal development as well (39, 40).
What are the proportions of TCRb1 cells arising by de
novo induction and by subsequent proliferation? During dg
13.5 and 14.5, most TCRb1 thymocytes appear as individ-
ually dispersed cells in CLSM. On dg 15.5, a greater num-
ber of TCRb1 cells with many doublets are seen, followed
by a further increase in density on dg 16.5. Thus, according
to CLSM, little cell division occurs for at least one day after
thymocytes first express a TCRb polypeptide. We there-
fore think that the z100 TCRb1 cells in dg 14.5 fetal thy-
mic lobes almost exclusively arise by independent induc-
tion events. In situ analyses of the TCRb1 population in
FTOC shows maintenance of the individually dispersed ap-
pearance of TCRb1 cells until day 11, and BrdU incorpo-
ration suggests that about one third of these cells have
arisen by cell division. Together, these results suggest that a
minimum of 300 of the 400 TCRb1 cells/thymic lobe af-
ter one day of FTOC arose by independent induction
events. Our data from CLSM and from BrdU incorpora-
tion in vivo suggest that at least half of the 1,200 TCRb1
cells/thymic lobe on dg 15.5 in vivo may be the products
of cell division, suggesting a maximum of 900 indepen-
dently induced TCRb1 cells until that time. Together, our
data suggest about 600, certainly less than the 1,000 inde-
pendently induced TCRb1 cells/thymic lobe until dg 15.5.
Thereafter, as shown by BrdU incorporation, TCRb1 cells
accumulate predominantly by cell division. Productive
TCRb locus rearrangement thus seems to take place in
Figure 7. (A) BrdU incorporation into fetal
thymic lobes recovered from BALB/c fetuses on
dg 13.5 and kept in organ culture for 1 d. Experi-
mental procedure and data representation essen-
tially as in Fig. 6, except that the negative controls
for BrdU staining are unmarked. (B) Triple analy-
sis for TCRb, BrdU incorporation, and PI stain-
ing of thymocytes recovered from dg 15.5 and
17.5 fetal thymic lobes of pregnant BALB/c
mothers injected 18 h earlier with BrdU. IC
TCRb staining and sorting not shown. Sorted
TCRb1 and TCRb2 cells were double stained
with PI (top, shaded patterns) and for BrdU incor-
poration (bottom). BrdU incorporation is shown
separately for cells with diploid (horizontal stripes)
and hyperdiploid (vertical stripes) PI staining. The
small difference in BrdU intensity between the
two populations is not significant, as there is some
spillover of PI fluorescence into the FITC chanel.
Negative controls (unmarked patterns) are as de-
scribed in Fig. 6. (C) Analysis of TCRb locus DJ
and VDJ rearrangements by PCR in dg 14.5 fetal
thymocytes (14.5), and in adult thymus (AT).
Ethidium bromide–stained gel shown, inversely
photographed. The six fragments seen with 59Vb8
and 59Vb3 primers correspond, from top to bot-
tom, from VDb2Jb2.1 to VDb2Jb2.6 rearrange-
ments. The additional fragment at the top of the
Db2 to Jb2 rearrangements represents the germ-
line configuration.2337 Falk et al.
,10% of the cells that have entered the thymus until dg
14.5, i.e., in a rather small proportion of thymocytes. Even
after subtraction of z10% gd thymocytes present at that
time, this is significantly less than statistically expected if all
remaining thymocytes were induced to rearrange their
TCRb genes. Induction of TCRb locus rearrangement
may thus be a relatively inefficient process in early fetal
thymocytes.
From day 11 of FTOC onwards, TCRb1 cells undergo
a series of rapid cell divisions resulting in a nearly 200-fold
expansion of this population within the following 3 d. This
expansion phase is indeed burst-like; it acquires maximum
speed (>3 divisions/d) on days 12 and 13, and returns to
a slow rate of about one–two divisions during the fourth
day. Estimates of cell divisions are derived from three mu-
tually supportive sources of information: cell counts by
FCM, BrdU incorporation, and morphodynamic studies
on the expansion of TCRVb clones in situ. The rates of
cell division estimated from the latter source are slightly
lower, possibly due to some degree of underestimation of
clone sizes in CLSM. Alternatively, clones expressing dif-
ferent TCRVb products may expand with somewhat dif-
ferent kinetics. The total accumulation of TCRb1 thy-
mocytes in 4 d of FTOC is z1/6–1/7 of that determined
until the corresponding dg 18.5 in vivo. Half of this differ-
ence is due to a slowdown in proliferation during the first
day of FTOC, leading to threefold less TCRb1 cells on
day 11 of culture than on dg 15.5 in vivo. Most of the
other half can perhaps be accounted for by lack of influx of
new precursor cells into the thymus. Thus, we estimate an
about 500-fold expansion of TCRb clones during the burst
in vivo, corresponding to about nine cell divisions within a
time frame of z4 d.
The biological purpose of pre-TCR dependent prolifer-
ation appears to be the selection for further maturation of
thymocytes with a functional rearrangement of the TCRb
locus, thus avoiding the further differentiation of useless
cells that have failed to productively rearrange a TCRb
gene. Our analyses of TCRb2 cells in FTOC reveals an
initial proportion of z30% in S/G2 which declines to
,10% over the 4 d of culture. Moreover, an initial propor-
tion of 3/4, declining to 1/2, becomes partially labeled
with BrdU during an 18 h pulse. Both sets of data are
roughly in agreement and suggest that the majority of
TCRb2 cells are indeed dividing between dg 14.5 and
18.5, but they do so at a slower rate than that of the
TCRb1 cells. With the exception of dg 14.5 to 15.5, the
increment of TCRb2 cells/day is , twofold in vitro and
in vivo. This results in an z8–14-fold increment in
TCRb2 cells until day 14 in FTOC or dg 18.5 in vivo,
consistant with one division/day of most, but not all cells.
We observed small but significant proportions of apoptotic
TCRb2 cells in vivo and in vitro, indicating that cells that
have failed to generate a productive TCRb rearrangement
eventually die by programmed cell death. The increase in
the proportion of nondividing TCRb2 cells over the 4 d is
consistent with the notion that shutdown of proliferation
preceeds cell death. Taken together, it appears that the ma-
jor mechanism of pre-TCR–dependent positive selection
of fetal thymocytes is a burst of up to nine rapid cell divi-
sions that begins within less than two day after TCRb ex-
pression and lasts for about 4 d. In contrast, lack of selec-
tion of TCRb2 cells is reflected in a limited maintenance
of slow proliferation, then shutdown of proliferation, and
eventual cell death by apoptosis.
What is the cell cycle status of TCRb1 cells on dg 13.5
and 14.5, i.e., before we can see doublet formation in
CLSM? As judged by PI staining .60% of TCRb1 cells
have entered S/G2 phase on dg 14.5, and TCRb1 cells in
G1 of cell cycle on dg 15.5 have incorporated BrdU during
an 18 h pulse. These in vivo results suggest that TCRb1
cells may begin to divide as early as dg 14.5. This conclu-
sion is further supported by our finding that many TCRb1
cells incorporate saturating amounts of BrdU on day 11 of
dg 13.5 FTOC. Nevertheless, our CLSM results suggest a
delay period between TCRb chain expression and the start
of cell proliferation. We could not exactly define this inter-
val but feel that for most thymocytes the burst of rapid di-
visions does not start until about one day following expres-
sion of the TCRb chain, and that most of this delay may
be spent in the G2 phase of cell cycle. An interesting set of
questions arising from these results concerns the potential
biological role of a delay before proliferation sets in: Does
proliferation perhaps require a second signal, for example
through cytokine–cytokine receptor interaction (47–49). Is
the delay phase important for DNA repair subsequent to
TCRb rearrangement, and how is this delay phase regu-
lated? Recent experiments suggest that p53 may perhaps
have an important role in regulating pre-TCR dependent
differentiation events (50).
How do these results on fetal thymocytes compare to
previous studies on proliferation of adult thymocyte sub-
sets? According to Shortman et al. (35) the maturation of
DN to DP thymocytes is accompanied by two phases of
proliferation, separated by the CD251CD442 DN stage in
which the cells are resting. The latter subset, at which
TCRb rearrangement takes place, was found by Penit et al.
(36) and by Hoffman et al. (37) to be split into dividing and
nondividing cells. Although not directly shown, the divid-
ing and nondividing subsets were interpreted as TCRb1
and TCRb2 cells, respectively, and it was speculated that
the latter cells would die due to lack of positive selection. A
200–300 fold expansion takes place during the subsequent
proliferation phase which begins at the CD252CD442 DN
stage, ends with small resting DP cells, and lasts 6 d (35, 36).
As far as they can be compared, our results are roughly in
agreement with these data. For example, the numbers of
cell divisions and the expansion factors do not appear to
drastically differ between fetal and adult thymocytes. More-
over, the dividing TCRb2 subset in fetal thymus could
correspond to the first proliferative phase involving the im-
mature CD441CD252 population whereas the resting
TCRb2 subset in fetal thymocytes could potentially corre-
spond to the nondividing subset among the CD251CD4422338 Pre-TCR Dependent Fetal Thymocyte Proliferation
adult DN cells. The results described in this paper have
augmented previous knowledge primarily by firmly estab-
lishing the causal connection between the second phase of
thymocyte proliferation and the expression of the TCRb
chain, in addition to providing numerical information on
fetal thymocyte proliferation.
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